ITCI vs. TMO

Last updated Apr 2, 2026

Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Thermo Fisher Scientific Inc. (TMO).

Performance

ITCI vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intra-Cellular Therapies, Inc. (ITCI) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

ITCI vs. TMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ITCI Intra-Cellular Therapies, Inc.	0.00%	57.89%	16.62%	35.34%	1.11%	64.59%	-7.32%	201.23%	-21.34%	-4.04%
TMO Thermo Fisher Scientific Inc.	-14.57%	11.78%	-1.72%	-3.36%	-17.29%	43.54%	43.72%	45.55%	18.21%	35.03%

Fundamentals

Total Revenue (TTM) ITCI : $680.64M TMO : $44.56B
Gross Profit (TTM) ITCI : $623.67M TMO : $18.02B
EBITDA (TTM) ITCI : -$116.21M TMO : $11.35B

Returns By Period

ITCI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

TMO

• 1D: 0.61%
• 1M: -2.66%
• YTD: -14.57%
• 6M: -6.66%
• 1Y: 2.77%
• 3Y*: -4.68%
• 5Y*: 1.90%
• 10Y*: 13.56%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ITCI vs. TMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO

TMO Risk / Return Rank: 39
TMO Sharpe Ratio Rank: 43
TMO Sortino Ratio Rank: 38
TMO Omega Ratio Rank: 37
TMO Calmar Ratio Rank: 40
TMO Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ITCI vs. TMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ITCI	TMO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.09	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.07	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.52	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.41	—

Correlation

The correlation between ITCI and TMO is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ITCI vs. TMO - Dividend Comparison

ITCI has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.36%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ITCI Intra-Cellular Therapies, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TMO Thermo Fisher Scientific Inc.	0.36%	0.30%	0.30%	0.26%	0.22%	0.16%	0.19%	0.23%	0.30%	0.32%	0.43%	0.42%

Drawdowns

Drawdown Indicators

	ITCI	TMO	Difference
Max Drawdown Largest peak-to-trough decline	—	-71.16%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-27.31%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-40.95%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-40.95%	—
Current Drawdown Current decline from peak	—	-24.98%	—
Average Drawdown Average peak-to-trough decline	—	-17.97%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	12.13%	—

Volatility

Volatility by Period

	ITCI	TMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	8.84%	—
Volatility (6M) Calculated over the trailing 6-month period	—	19.06%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	32.87%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	26.59%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	25.93%	—

Financials